Bon Secours Mary Immaculate Hospital — Newport News, Virginia

Bon Secours Mary Immaculate Hospital is a clinical research site located in Newport News, Virginia, United States 23602.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Bon Secours Mary Immaculate Hospital has participated in 7 clinical trials.

Therapeutic areas: Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7.

Sponsors: GOG Foundation, Conatus Pharmaceuticals Inc., National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bon Secours Mary Immaculate Hospital?

Bon Secours Mary Immaculate Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bon Secours Mary Immaculate Hospital conducted?

Bon Secours Mary Immaculate Hospital has 7 clinical trials on record. Their work covers Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7.

Is Bon Secours Mary Immaculate Hospital accredited by Crixeo Health?

Yes — Bon Secours Mary Immaculate Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Bon Secours Mary Immaculate Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.